CLINICAL_TRIALS
trial_result
· 2018-05-09
Clinical Trial Update: A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC) [Phase 2, Phase 3]
Summary
This update notes the completion of Phase 2 and Phase 3 trials conducted by the TRAC collaboration on falciparum malaria.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Oxford | Conditions: Malaria, Falciparum | Phase 2, Phase 3 | Status: COMPLETED